These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 9635841)
1. Mutation analysis of the c-mos proto-oncogene in human ovarian teratomas. de Foy KA; Gayther SA; Colledge WH; Crockett S; Scott IV; Evans MJ; Ponder BA Br J Cancer; 1998 May; 77(10):1642-4. PubMed ID: 9635841 [TBL] [Abstract][Full Text] [Related]
2. Ovarian teratomas in mice lacking the protooncogene c-mos. Furuta Y; Shigetani Y; Takeda N; Iwasaki K; Ikawa Y; Aizawa S Jpn J Cancer Res; 1995 Jun; 86(6):540-5. PubMed ID: 7622418 [TBL] [Abstract][Full Text] [Related]
3. Mos oncogene expression in human ovarian tumors. Xerri L; Charpin C; Hassoun J; Birnbaum D; Delapeyriere O Anticancer Res; 1991; 11(4):1629-34. PubMed ID: 1836123 [TBL] [Abstract][Full Text] [Related]
4. Parthenogenetic activation of oocytes in c-mos-deficient mice. Hashimoto N; Watanabe N; Furuta Y; Tamemoto H; Sagata N; Yokoyama M; Okazaki K; Nagayoshi M; Takeda N; Ikawa Y Nature; 1994 Jul; 370(6484):68-71. PubMed ID: 8015610 [TBL] [Abstract][Full Text] [Related]
5. Mutations of the KIT gene and loss of heterozygosity of the PTEN region in a primary malignant melanoma arising from a mature cystic teratoma of the ovary. Tate G; Tajiri T; Suzuki T; Mitsuya T Cancer Genet Cytogenet; 2009 Apr; 190(1):15-20. PubMed ID: 19264228 [TBL] [Abstract][Full Text] [Related]
6. Methylation profile of imprinted genes provides evidence for teratomatous origin of a subset of mucinous ovarian tumours. Kato N; Kamataki A; Kurotaki H J Pathol; 2021 Aug; 254(5):567-574. PubMed ID: 33983633 [TBL] [Abstract][Full Text] [Related]
7. Pseudomyxoma peritonei of a mature ovarian teratoma caused by mismatch repair deficiency in a patient with Lynch syndrome: a case report. Gohda Y; Noguchi R; Horie T; Igari T; Nakamura H; Ohta Y; Yamaguchi K; Ikenoue T; Hatakeyama S; Yusa N; Furukawa Y; Yano H BMC Med Genet; 2016 Dec; 17(1):94. PubMed ID: 27938333 [TBL] [Abstract][Full Text] [Related]
8. Mucinous epithelial tumours arising from ovarian mature teratomas: a tissue genotyping study. Snir OL; Buza N; Hui P Histopathology; 2016 Sep; 69(3):383-92. PubMed ID: 26952875 [TBL] [Abstract][Full Text] [Related]
10. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics. Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247 [TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer BRCA1 mutation detection: Protein truncation test (PTT) outperforms single strand conformation polymorphism analysis (SSCP). Geisler JP; Hatterman-Zogg MA; Rathe JA; Lallas TA; Kirby P; Buller RE Hum Mutat; 2001 Oct; 18(4):337-44. PubMed ID: 11668617 [TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: four germline mutations, but no evidence of somatic mutation. Matsushima M; Kobayashi K; Emi M; Saito H; Saito J; Suzumori K; Nakamura Y Hum Mol Genet; 1995 Oct; 4(10):1953-6. PubMed ID: 8595420 [TBL] [Abstract][Full Text] [Related]
13. Significance of p53 expression in immature teratomas. Charoenkwan P; Senger C; Weitzman S; Sexsmith E; Sherman CG; Malkin D; Thorner PS Pediatr Dev Pathol; 2002; 5(5):499-507. PubMed ID: 12202994 [TBL] [Abstract][Full Text] [Related]
14. Mutations of the BRCA2 gene in ovarian carcinomas. Takahashi H; Chiu HC; Bandera CA; Behbakht K; Liu PC; Couch FJ; Weber BL; LiVolsi VA; Furusato M; Rebane BA; Cardonick A; Benjamin I; Morgan MA; King SA; Mikuta JJ; Rubin SC; Boyd J Cancer Res; 1996 Jun; 56(12):2738-41. PubMed ID: 8665505 [TBL] [Abstract][Full Text] [Related]
15. Struma Ovarii With Malignant Transformation and Germline KIT Mutation: A Case Report With Review of the Literature. Ma D; Guseva NV; Dahmoush L; Robinson RA Int J Gynecol Pathol; 2016 Sep; 35(5):442-7. PubMed ID: 27258816 [TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer has frequent loss of heterozygosity at chromosome 12p12.3-13.1 (region of TEL and Kip1 loci) and chromosome 12q23-ter: evidence for two new tumour-suppressor genes. Hatta Y; Takeuchi S; Yokota J; Koeffler HP Br J Cancer; 1997; 75(9):1256-62. PubMed ID: 9155043 [TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of the BRCA1 gene in ovarian cancers. Takahashi H; Behbakht K; McGovern PE; Chiu HC; Couch FJ; Weber BL; Friedman LS; King MC; Furusato M; LiVolsi VA Cancer Res; 1995 Jul; 55(14):2998-3002. PubMed ID: 7606717 [TBL] [Abstract][Full Text] [Related]
19. Whole-exome sequencing identified the genetic origin of a mucinous neoplasm in a mature cystic teratoma. Choi YJ; Lee SH; Kim MS; Jung SH; Hur SY; Chung YJ; Lee SH Pathology; 2016 Jun; 48(4):372-6. PubMed ID: 27114374 [TBL] [Abstract][Full Text] [Related]